Blood test could spot cancer return months before scans
NCT ID NCT07382505
First seen Feb 02, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study will enroll 600 people with endometrial or cervical cancer to see if a blood test can detect cancer recurrence earlier than standard methods. Participants give blood samples at diagnosis, after treatment, and during follow-up. The goal is to improve monitoring and guide personalized treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
Seoul, Seoul, 05505, South Korea
Conditions
Explore the condition pages connected to this study.